Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Stenmark

Showing results (91-100 of 100) with videos related to

Pageof 10
Sort By:
You have reached the last page of results.This site can display upto 100 results.
The Journal of Biological Chemistry|June 2, 1995
EEA1, an early endosome-associated protein. EEA1 is a conserved alpha-helical peripheral membrane protein flanked by cysteine "fingers" and contains a calmodulin-binding IQ motifF T Mu, J M Callaghan, O Steele-Mortimer, et al.
Oral Oncology|January 7, 2014
Reliability of post-chemoradiotherapy F-18-FDG PET/CT for prediction of locoregional failure in human papillomavirus-associated oropharyngeal cancerJeffrey M Vainshtein, Matthew E Spector, Matthew H Stenmark, et al.
Advances in Radiation Oncology|November 9, 2017
Neoadjuvant twice daily chemoradiotherapy for esophageal cancer: Treatment-related mortality and long-term outcomesStuart E Samuels, Matthew H Stenmark, Jae Y Lee, et al.
International Journal of Radiation Oncology, Biology, Physics|December 26, 2012
Age and comorbid illness are associated with late rectal toxicity following dose-escalated radiation therapy for prostate cancerDaniel A Hamstra, Matt H Stenmark, Tim Ritter, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|February 11, 2014
Dose to the inferior rectum is strongly associated with patient reported bowel quality of life after radiation therapy for prostate cancerMatthew H Stenmark, Anna S C Conlon, Skyler Johnson, et al.
Head & Neck|April 28, 2015
Matted nodes: High distant-metastasis risk and a potential indication for intensification of systemic therapy in human papillomavirus-related oropharyngeal cancerJeffrey M Vainshtein, Matthew E Spector, Mohannad Ibrahim, et al.
Head & Neck|June 26, 2014
Human papillomavirus-related oropharyngeal cancer: HPV and p16 status in the recurrent versus parent tumorJeffrey Vainshtein, Jonathan B McHugh, Matthew E Spector, et al.
International Journal of Radiation Oncology, Biology, Physics|February 14, 2014
Nonendemic HPV-positive nasopharyngeal carcinoma: association with poor prognosisMatthew H Stenmark, Jonathan B McHugh, Matthew Schipper, et al.
Oral Oncology|February 26, 2014
Refining risk stratification for locoregional failure after chemoradiotherapy in human papillomavirus-associated oropharyngeal cancerJeffrey M Vainshtein, Matthew E Spector, Jonathan B McHugh, et al.
JAMA Otolaryngology-- Head & Neck Surgery|November 2, 2013
High-risk human papillomavirus detection in oropharyngeal, nasopharyngeal, and oral cavity cancers: comparison of multiple methodsHeather M Walline, Chris Komarck, Jonathan B McHugh, et al.
Pageof 10

Showing results (91-100 of 100) with videos related to

Sort By:
Pageof 10
You have reached the last page of results.This site can display upto 100 results.
The Journal of Biological Chemistry|June 2, 1995
EEA1, an early endosome-associated protein. EEA1 is a conserved alpha-helical peripheral membrane protein flanked by cysteine "fingers" and contains a calmodulin-binding IQ motifF T Mu, J M Callaghan, O Steele-Mortimer, et al.
Oral Oncology|January 7, 2014
Reliability of post-chemoradiotherapy F-18-FDG PET/CT for prediction of locoregional failure in human papillomavirus-associated oropharyngeal cancerJeffrey M Vainshtein, Matthew E Spector, Matthew H Stenmark, et al.
Advances in Radiation Oncology|November 9, 2017
Neoadjuvant twice daily chemoradiotherapy for esophageal cancer: Treatment-related mortality and long-term outcomesStuart E Samuels, Matthew H Stenmark, Jae Y Lee, et al.
International Journal of Radiation Oncology, Biology, Physics|December 26, 2012
Age and comorbid illness are associated with late rectal toxicity following dose-escalated radiation therapy for prostate cancerDaniel A Hamstra, Matt H Stenmark, Tim Ritter, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|February 11, 2014
Dose to the inferior rectum is strongly associated with patient reported bowel quality of life after radiation therapy for prostate cancerMatthew H Stenmark, Anna S C Conlon, Skyler Johnson, et al.
Head & Neck|April 28, 2015
Matted nodes: High distant-metastasis risk and a potential indication for intensification of systemic therapy in human papillomavirus-related oropharyngeal cancerJeffrey M Vainshtein, Matthew E Spector, Mohannad Ibrahim, et al.
Head & Neck|June 26, 2014
Human papillomavirus-related oropharyngeal cancer: HPV and p16 status in the recurrent versus parent tumorJeffrey Vainshtein, Jonathan B McHugh, Matthew E Spector, et al.
International Journal of Radiation Oncology, Biology, Physics|February 14, 2014
Nonendemic HPV-positive nasopharyngeal carcinoma: association with poor prognosisMatthew H Stenmark, Jonathan B McHugh, Matthew Schipper, et al.
Oral Oncology|February 26, 2014
Refining risk stratification for locoregional failure after chemoradiotherapy in human papillomavirus-associated oropharyngeal cancerJeffrey M Vainshtein, Matthew E Spector, Jonathan B McHugh, et al.
JAMA Otolaryngology-- Head & Neck Surgery|November 2, 2013
High-risk human papillomavirus detection in oropharyngeal, nasopharyngeal, and oral cavity cancers: comparison of multiple methodsHeather M Walline, Chris Komarck, Jonathan B McHugh, et al.
Pageof 10